HAMILTON BEACH BRANDS HOLDING CO, 10-Q filed on 8/5/2026
Quarterly Report
v3.26.1
Cover Page - shares
6 Months Ended
Jun. 30, 2026
Jul. 31, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Transition Report false  
Entity File Number 001-38214  
Entity Registrant Name HAMILTON BEACH BRANDS HOLDING COMPANY  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 31-1236686  
Entity Address, Address Line One 4421 WATERFRONT DR.  
Entity Address, City or Town GLEN ALLEN  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 23060  
City Area Code (804)  
Local Phone Number 273-9777  
Title of 12(b) Security Class A Common Stock, Par Value $0.01 Per Share  
Trading Symbol HBB  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001709164  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Class A Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   9,858,179
Class B Common stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   3,584,153
v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Current assets      
Cash and cash equivalents $ 101,469 $ 47,313 $ 11,338
Trade receivables, net 99,097 110,535 74,093
Inventory 115,125 133,833 160,357
Prepaid expenses and other current assets 14,434 13,052 14,318
Total current assets 330,125 304,733 260,106
Property, plant and equipment, net 25,534 30,253 33,464
Right-of-use lease assets 32,557 34,614 36,956
Goodwill 7,099 7,099 7,099
Deferred income taxes 3,520 3,607 7,513
Other non-current assets 12,451 17,318 18,666
Total assets 411,286 397,624 363,804
Current liabilities      
Accounts payable 69,674 86,376 76,275
Accrued compensation 8,930 13,956 7,127
Accrued product returns 7,907 7,875 7,072
Lease liabilities 5,560 5,497 5,568
Other current liabilities 13,282 9,529 9,450
Total current liabilities 105,353 123,233 105,492
Revolving credit agreements 50,000 50,000 50,000
Lease liabilities, non-current 34,030 36,416 38,988
Other long-term liabilities 5,169 5,130 5,349
Total liabilities 194,552 214,779 199,829
Stockholders’ equity      
Preferred stock, par value $0.01 per share 0 0 0
Capital in excess of par value 83,389 80,795 78,673
Treasury stock (38,376) (35,213) (33,549)
Retained earnings 177,821 143,888 126,919
Accumulated other comprehensive loss (6,257) (6,780) (8,222)
Total stockholders’ equity 216,734 182,845 163,975
Total liabilities and stockholders’ equity 411,286 397,624 363,804
Class A Common stock      
Stockholders’ equity      
Common stock 121 119 118
Class B Common stock      
Stockholders’ equity      
Common stock $ 36 $ 36 $ 36
v3.26.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Statement of Financial Position [Abstract]      
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 142,632 $ 127,770 $ 264,595 $ 261,142
Cost of sales 65,136 92,639 150,907 193,240
Gross profit 77,496 35,131 113,688 67,902
Selling, general and administrative expenses 34,290 29,183 65,514 59,641
Operating profit (loss) 43,206 5,948 48,174 8,261
Interest (income) expense, net (1,264) 121 (1,342) 49
Other (income) expense, net (160) (182) (66) (331)
Income (loss) before income taxes 44,630 6,009 49,582 8,543
Income tax expense (benefit) 10,922 1,556 12,335 2,285
Net income (loss) $ 33,708 $ 4,453 $ 37,247 $ 6,258
Basic earnings (loss) per share (in dollars per share) $ 2.50 $ 0.33 $ 2.75 $ 0.46
Diluted earnings (loss) per share (in dollars per share) $ 2.49 $ 0.33 $ 2.75 $ 0.46
Basic weighted average shares outstanding (in shares) 13,496 13,516 13,534 13,642
Diluted weighted average shares outstanding (in shares) 13,512 13,534 13,551 13,661
v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 33,708 $ 4,453 $ 37,247 $ 6,258
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustment 409 2,660 119 2,987
Cash flow hedging activity 275 (1,115) 564 (1,735)
Reclassification of hedging activities into earnings (193) (472) (152) (952)
Reclassification related to pension termination activity into earnings 0 2 0 48
Reclassification of pension adjustments into earnings (2) 5 (8) 7
Total other comprehensive income (loss), net of tax 489 1,080 523 355
Comprehensive income (loss) $ 34,197 $ 5,533 $ 37,770 $ 6,613
v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net income (loss) $ 37,247 $ 6,258
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Depreciation and amortization 5,406 2,518
Stock compensation expense 2,596 2,008
Other 395 (1,294)
Net changes in operating assets and liabilities:    
Trade receivables 11,835 44,391
Inventory 18,274 (33,599)
Other assets 6,500 10,856
Accounts payable (16,964) (27,950)
Other liabilities (3,746) (26,961)
Net cash provided by (used for) operating activities 61,543 (23,773)
Investing activities    
Expenditures for property, plant and equipment (895) (1,466)
Net cash provided by (used for) investing activities (895) (1,466)
Financing activities    
Cash dividends paid (3,314) (3,202)
Purchase of treasury stock (3,163) (7,347)
Net cash provided by (used for) financing activities (6,477) (10,549)
Effect of exchange rate changes on cash and cash equivalents (15) 602
Cash and cash equivalents    
Increase (decrease) for the period 54,156 (35,186)
Balance at the beginning of the period 47,313 46,524
Balance at the end of the period $ 101,469 $ 11,338
v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Class A Common stock
Common Stock
Class B Common stock
Capital in Excess of Par Value
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2024 $ 165,903 $ 115 $ 36 $ 76,668 $ (26,202) $ 123,863 $ (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 1,805         1,805  
Issuance of common stock, net of conversions 0 3   (3)      
Purchase of treasury stock (3,373)       (3,373)    
Share-based compensation expense 1,156     1,156      
Cash dividends (1,585)         (1,585)  
Other comprehensive income (loss), net of tax (293)           (293)
Reclassification adjustment to net income (loss) (432)           (432)
Ending balance at Mar. 31, 2025 163,181 118 36 77,821 (29,575) 124,083 (9,302)
Beginning balance at Dec. 31, 2024 165,903 115 36 76,668 (26,202) 123,863 (8,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 6,258            
Purchase of treasury stock (7,400)            
Ending balance at Jun. 30, 2025 163,975 118 36 78,673 (33,549) 126,919 (8,222)
Beginning balance at Dec. 31, 2024 165,903 115 36 76,668 (26,202) 123,863 (8,577)
Ending balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Beginning balance at Mar. 31, 2025 163,181 118 36 77,821 (29,575) 124,083 (9,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 4,453         4,453  
Purchase of treasury stock (3,974)       (3,974)    
Share-based compensation expense 852     852      
Cash dividends (1,617)         (1,617)  
Other comprehensive income (loss), net of tax 1,545           1,545
Reclassification adjustment to net income (loss) (465)           (465)
Ending balance at Jun. 30, 2025 163,975 118 36 78,673 (33,549) 126,919 (8,222)
Beginning balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 3,539         3,539  
Issuance of common stock, net of conversions 0 2   (2)      
Purchase of treasury stock (1,206)       (1,206)    
Share-based compensation expense 1,186     1,186      
Cash dividends (1,629)         (1,629)  
Other comprehensive income (loss), net of tax (1)           (1)
Reclassification adjustment to net income (loss) 35           35
Ending balance at Mar. 31, 2026 184,769 121 36 81,979 (36,419) 145,798 (6,746)
Beginning balance at Dec. 31, 2025 182,845 119 36 80,795 (35,213) 143,888 (6,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 37,247            
Purchase of treasury stock (3,200)            
Ending balance at Jun. 30, 2026 216,734 121 36 83,389 (38,376) 177,821 (6,257)
Beginning balance at Mar. 31, 2026 184,769 121 36 81,979 (36,419) 145,798 (6,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 33,708         33,708  
Purchase of treasury stock (1,957)       (1,957)    
Share-based compensation expense 1,410     1,410      
Cash dividends (1,685)         (1,685)  
Other comprehensive income (loss), net of tax 684           684
Reclassification adjustment to net income (loss) (195)           (195)
Ending balance at Jun. 30, 2026 $ 216,734 $ 121 $ 36 $ 83,389 $ (38,376) $ 177,821 $ (6,257)
v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares
3 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Statement of Stockholders' Equity [Abstract]        
Cash dividends (in dollars per share) $ 0.125 $ 0.12 $ 0.12 $ 0.115
v3.26.1
Basis of Presentation and Recently Issued Accounting Standards
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Recently Issued Accounting Standards Basis of Presentation and Recently Issued Accounting Standards
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”).

We are a leading designer, marketer and distributor of a wide range of brand name small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars and hotels, and a provider of connected devices and software for home healthcare management.

Our operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Certain prior period amounts have been reclassified to conform to the current period classification. These reclassifications had no effect on the reported operating profit, net income, or stockholders’ equity.

Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the remainder of the year as our revenue typically increases during the second half of the year and peaks during the fourth quarter due to the fall holiday-selling season. Accordingly, quarter-to-quarter comparisons of our past operating results are meaningful only when comparing equivalent time periods, if at all.

We maintain a $125.0 million senior secured floating-rate revolving credit facility (the “HBB Facility”) that expires on December 13, 2029. We believe funds available from cash on hand, the HBB Facility and operating cash flows will provide sufficient liquidity to meet our operating needs and commitments arising during the next twelve months.

Recently Issued Accounting Standards Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
In September 2025, the FASB issued ASU 2025-06, “Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40):Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements.” The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for annual periods beginning after December 15, 2027, including interim periods within that annual period. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.

Accounts Payable - Supplier Finance Program

The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements.

As of June 30, 2026, December 31, 2025 and June 30, 2025, the Company had $26.5 million, $29.9 million and $35.8 million, respectively, in outstanding payment obligations to the third-party financial institution that are presented in accounts payable on the Consolidated Balance Sheets. There is no requirement to provide assets pledged as security or other forms of guarantees under the agreement. The Company pays the third-party financial institution based upon the original payment terms negotiated with participating suppliers. The payment of these obligations by the Company is included in cash provided by operating activities in the Consolidated Statements of Cash Flows.

The agreement limits payment obligations owed by the Company but sold by participating suppliers to $65.0 million. Of the amounts owed by the Company referenced above that are presented in accounts payable, participating suppliers have sold $20.1 million, $21.8 million and $32.0 million, as of June 30, 2026, December 31, 2025 and June 30, 2025, respectively.
v3.26.1
Transfer of Financial Assets
6 Months Ended
Jun. 30, 2026
Transfers and Servicing [Abstract]  
Transfer of Financial Assets Transfer of Financial Assets
The Company has an arrangement with a financial institution to sell certain U.S. trade receivables of a single customer on a non-recourse basis. Under the terms of the agreement, the Company receives cash proceeds and retains no rights or interest and has no obligations with respect to the sold receivables. These transactions, which are accounted for as sold receivables, result in a reduction in trade receivables because the agreement transfers effective control over and risk related to the receivables to the buyer. Under this arrangement, the Company derecognized $0.0 million and $4.3 million of trade receivables during the three and six months ended June 30, 2026, respectively, $34.2 million and $66.6 million during the three and six months ended June 30, 2025, respectively, and $145.0 million during the year ended December 31, 2025. The decrease in derecognized trade receivables for the three and six months ended June 30, 2026 is due to the Company’s decision to transition away from the arrangement. The loss incurred on sold receivables in the Consolidated Statements of Operations for the three and six months ended June 30, 2026 and 2025 was not material. The Company does not carry any servicing assets or liabilities. Cash proceeds from this arrangement are reflected as operating activities in the Consolidated Statements of Cash Flows.
v3.26.1
Fair Value Disclosure
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Disclosure Fair Value Disclosure
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationJUNE 30
2026
DECEMBER 31
2025
JUNE 30
2025
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$1,151 $831 $864 
Long-termOther non-current assets1,091 1,199 1,674 
$2,242 $2,030 $2,538 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities 126 1,223 
$ $126 $1,223 

The Company measures its derivatives at fair value using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. The Company uses a present value technique that incorporates the Secured Overnight Financing Rate (SOFR) swap curve, foreign currency spot rates and foreign currency forward rates to value its derivatives, including its interest rate swap agreements and foreign currency exchange contracts. The Company also incorporates the effect of HBB and counterparty credit risk into the valuation.

Other Fair Value Measurement Disclosures

The carrying amounts of cash and cash equivalents, trade receivables and accounts payable approximate fair value due to the short-term maturities of these instruments.

The $125.0 million fair value of the HBB Facility, including book overdrafts, which approximate book value, was determined using current rates offered for similar obligations taking into account the Company’s credit risk, which is Level 2 as defined in the fair value hierarchy.

The Company does not hold any Level 3 assets or liabilities and there were no transfers into or out of Levels 1, 2 or 3 during the three and six months ended June 30, 2026.
v3.26.1
Stockholders’ Equity
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Capital Stock 

The following table sets forth the Company’s authorized capital stock information:
JUNE 30
2026
DECEMBER 31
2025
JUNE 30
2025
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
12,083 11,870 11,821 
Treasury Stock (3)
2,219 2,052 1,941 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,584 3,587 3,596 

(1) Class B Common converted to Class A Common were 1 and 3 shares during the three and six months ended June 30, 2026, respectively, and 5 and 7 shares during the three and six months ended June 30, 2025, respectively.

(2) The Company issued Class A Common of 18 and 210 shares during the three and six months ended June 30, 2026, respectively, and 19 and 338 shares during the three and six months ended June 30, 2025, respectively.

(3) On February 20, 2026 and February 21, 2025, a total of 14 and 39 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.

Stock Repurchase Program: In November 2025, the Company’s Board approved a stock repurchase program for the purchase of up to $25 million of the Company’s Class A Common outstanding starting January 1, 2026 and ending December 31, 2027. This program replaced the previous stock repurchase plan that started January 1, 2024 and ended December 31, 2025. During the three and six months ended June 30, 2026, the Company repurchased 97,869 and 153,282 shares at prevailing market prices for an aggregate purchase price of $2.0 million and $2.9 million, respectively. During the three and six months ended June 30, 2025, the Company repurchased 215,297 and 356,732 shares at prevailing market prices for an aggregate purchase price of $4.0 million and $6.7 million, respectively. During the year ended December 31, 2025, the Company repurchased 467,804 shares for an aggregate purchase price of $8.3 million. As of June 30, 2026, the Company had $22.1 million remaining authorized for repurchase.

Additionally, during the six months ended June 30, 2026 and June 30, 2025, the Company withheld shares for tax payments due upon issuance of stock to employees under the Incentive Plan. During the six months ended June 30, 2026 and June 30, 2025, the Company repurchased 13,575 and 39,121 shares, respectively, for an aggregate purchase price of $0.3 million and $0.7 million, respectively, pursuant to the Incentive Plan. There were no shares repurchased pursuant to the Incentive Plan during the three months ended June 30, 2026 and June 30, 2025.

The total combined share repurchases from the stock repurchase program and the Incentive Plan during the three and six months ended June 30, 2026 was 97,869 and 166,857 shares, respectively, for an aggregate purchase price of $2.0 million and $3.2 million, respectively. The total combined share repurchases from the stock repurchase program and the Incentive Plan during the three and six months ended June 30, 2025 was 215,297 and 395,853 shares, respectively, for an aggregate purchase price of $4.0 million and $7.4 million, respectively.
Accumulated Other Comprehensive Loss: The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2026$(8,365)$1,096 $489 $(6,780)
Other comprehensive income (loss)(290)383  93 
Reclassification adjustment to net income (loss) 80 (6)74 
Tax effects (133) (133)
Balance, March 31, 2026(8,655)1,426 483 (6,746)
Other comprehensive income (loss)409 364  773 
Reclassification adjustment to net income (loss) (254)(2)(256)
Tax effects (28) (28)
Balance, June 30, 2026$(8,246)$1,508 $481 $(6,257)
Balance, January 1, 2025$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)327 (861)— (534)
Reclassification adjustment to net income (loss)— (654)64 (590)
Tax effects— 415 (16)399 
Balance, March 31, 2025(11,952)2,472 178 (9,302)
Other comprehensive income (loss)2,660 (1,567)— 1,093 
Reclassification adjustment to net income (loss)— (637)(630)
Tax effects— 617 — 617 
Balance, June 30, 2025$(9,292)$885 $185 $(8,222)
v3.26.1
Revenue
6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services, which includes an estimate for variable consideration.

The Company’s warranty program to the consumer consists generally of an assurance-type limited warranty for electric appliances, with the majority of products having a warranty of one to three years. There is no guarantee to the consumer as the Company may repair or replace, at its discretion, products returned under warranty. Accordingly, the Company determined that no separate performance obligation exists.

Most of the Company’s products are not sold with a general right of return. Subject to certain terms and conditions, however, the Company will agree to accept a portion of products sold that, based on historical experience, are estimated to be returned for reasons such as product failure and excess inventory stocked by the customer. Product returns, customer programs and incentive offerings, including special pricing agreements, price competition, promotions and other volume-based incentives are accounted for as variable consideration.
A description of revenue sources and performance obligations for the Company are as follows:

Consumer and Commercial product revenue
Transactions with both consumer and commercial customers generally originate upon the receipt of a purchase order from a customer, which in some cases are governed by master sales agreements, specifying product(s) that the customer desires. Contracts for product revenue have an original duration of one year or less, and payment terms are generally standard and based on customer creditworthiness. Revenue from product sales is recognized at the point in time when control transfers to the customer, which is either when a product is shipped from a Company facility, or delivered to customers, depending on the shipping terms. The amount of revenue recognized varies primarily with price concessions and changes in returns. The Company offers price concessions to its customers for incentive offerings, special pricing agreements, price competition, promotions or other volume-based arrangements. The Company evaluated such agreements with its customers and determined returns and price concessions should be accounted for as variable consideration.

Consumer product revenue consists of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. A majority of this revenue is in North America.

Commercial product revenue consists of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales are in the U.S. and the remaining is in markets across the globe.

License revenue
From time to time, the Company enters into licensing agreements which grant the right to use certain of the Company’s intellectual property (“IP”) in connection with designing, manufacturing, distributing, advertising, promoting and selling the licensees’ products during the term of the agreement. The IP that is licensed generally consists of trademarks, trade names, patents, trade dress, logos and/or products (the “Licensed IP”). In exchange for granting the right to use the Licensed IP, the Company receives a royalty payment, which is a function of (1) the total net sales of products that use the Licensed IP and (2) the royalty percentage that is stated in the licensing agreement. The Company recognizes revenue at the later of when the subsequent sales occur or when the performance obligation is satisfied over time.

Additionally, the Company enters into agreements which grant the right to use software for healthcare management. The Company receives a license payment which is recognized when the performance obligation is satisfied over time or as usage occurs based on the contract with the customer.

Lease revenue
The Company leases connected devices to specialty pharmacy networks and pharmaceutical companies and is accounted for under Accounting Standards Codification 842, Leases as operating leases.

The following table sets forth Company’s revenue on a disaggregated basis for the three and six months ended June 30:
THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
2026202520262025
Type of good or service:
  Consumer products$122,201 $109,608 $228,321 $226,943 
  Commercial products16,296 14,643 28,221 26,935 
  Licensing2,152 2,208 4,136 4,768 
  Leasing1,983 1,311 3,917 2,496 
     Total revenues$142,632 $127,770 $264,595 $261,142 
v3.26.1
Contingencies
6 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, environmental and other claims. Although it is difficult to predict the ultimate outcome of these proceedings and claims, the Company believes the ultimate disposition of these matters will not have a material adverse effect on the financial condition, results of operation or cash flows of the Company. Any costs that the Company estimates will be paid as a result of these claims are accrued when the liability is considered probable and the amount of such costs can be reasonably estimated. The Company does not accrue liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated or when the liability is believed to be only reasonably possible or remote. For contingencies where an unfavorable outcome is probable or reasonably possible and which are material, the Company discloses the nature of the contingency and, in some circumstances, an estimate of the possible loss.

Tariff matters (IEEPA)

On February 20, 2026, the United States Supreme Court (“Court”) issued a ruling that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the U.S. President to impose tariffs. The Court’s ruling invalidated tariffs previously implemented by the U.S. Presidential Administration pursuant to IEEPA (“IEEPA Ruling”). As a result of this ruling, the Company began filing refund claims through the U.S. Customs and Border Protection’s (“CBP”) Consolidated Administration and Processing of Entries (“CAPE”) system. The Company has elected to apply a gain contingency model to account for potential recoveries of previously paid IEEPA tariffs (“IEEPA Tariff Refunds”) and any related interest received. Under this model, a gain contingency is not recognized in the consolidated financial statements until the gain is realized or realizable. Any remaining recovery, when recognized, would be reflected as a reduction of inventory to the extent the related goods remain on hand, or as a reduction of cost of sales for amounts related to goods already sold. As of June 30, 2026 the Company has received $36.5 million of IEEPA Tariff Refunds and recognized such refunds as a reduction of cost of sales in the Consolidated Statements of Operations for both the three and six months ended June 30, 2026. The Company has also received $1.2 million of interest associated with the IEEPA Tariff Refunds and recognized this within interest (income) expense, net in the Consolidated Statements of Operations for both the three and six months ended June 30, 2026.

Environmental matters

The Company is investigating or remediating historical environmental contamination at some current and former sites operated by the Company or by businesses the Company has acquired. The estimate of future investigation and remediation costs is primarily based on variables associated with site clean-up, including, but not limited to, physical characteristics of the site, the nature and extent of the contamination and applicable regulatory programs and remediation standards. The Company continues to monitor environmental matters and as of June 30, 2026, management has determined that such obligations are not material to the Company’s financial position, results of operations, or cash flows.
v3.26.1
Income Taxes
6 Months Ended
Jun. 30, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company’s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period.

The effective tax rate was 24.5% and 25.9% for the three months ended June 30, 2026 and 2025, respectively, and 24.9% and 26.7% for the six months ended June 30, 2026 and 2025, respectively. The lower effective tax rates in 2026 for both periods were due to changes in the jurisdictional mix of earnings and a reduction in foreign losses subject to a valuation allowance.
v3.26.1
Segment Information
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health. These segments are organized principally by product and service category. The Company’s reportable segments are determined based on (1) financial information reviewed by the chief operating decision maker “CODM”, (2) operational structure of the Company which is designed and managed to share resources across the entire suite of products offered by the business, and (3) the basis upon which the CODM makes resource allocation decisions. The CODM for both segments is the President and Chief Executive Officer of the Company. The CODM utilizes the segment operating profit (loss) to assess profitability and performance of actual results compared to forecasts.

The types of products and services from which each reportable segment derives its revenues are as follows:

Home and Commercial Products
Our Home and Commercial Products segment includes consumer product revenue, primarily concentrated in North America, consisting of sales of small electric household and specialty housewares appliances to traditional brick and mortar and ecommerce retailers, distributors and directly to the end consumer. Also included in this segment is commercial product revenue consisting of sales of products for restaurants, fast-food chains, bars and hotels. Approximately two-thirds of the Company’s commercial sales is in the U.S. and the remaining is in markets across the globe.

Health
Our Health segment includes lease revenue in the U.S. and globally associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue associated with agreements which grant customers the right to use software for healthcare management.
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

THREE MONTHS ENDED JUNE 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$140,172 $2,460 $142,632 $126,072 $1,698 $127,770 
Less:
Cost of sales64,579 557 65,136 92,149 490 92,639 
Selling, general and administrative expenses32,485 1,805 34,290 27,111 2,072 29,183 
Segment profit (loss)$43,108 $98 $43,206 $6,812 $(864)$5,948 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,264)121 
Other (income) expense, net(160)(182)
Income (loss) before income taxes$44,630 $6,009 

SIX MONTHS ENDED JUNE 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$259,783 $4,812 $264,595 $257,900 $3,242 $261,142 
Less:
Cost of sales149,772 1,135 150,907 192,375 865 193,240 
Selling, general and administrative expenses62,028 3,486 65,514 55,528 4,113 59,641 
Segment profit (loss)$47,983 $191 $48,174 $9,997 $(1,736)$8,261 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,342)49 
Other (income) expense, net(66)(331)
Income (loss) before income taxes$49,582 $8,543 
v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Basis of Presentation and Recently Issued Accounting Standards (Policies)
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

Throughout this Quarterly Report on Form 10-Q and the notes to unaudited consolidated financial statements, references to “Hamilton Beach Holding”, “the Company”, “we”, “us” and “our” and similar references are to Hamilton Beach Brands Holding Company and its subsidiaries on a consolidated basis unless otherwise noted or as the context otherwise requires. Hamilton Beach Brands Holding Company is a holding company and operates through its indirect, wholly owned subsidiary, Hamilton Beach Brands, Inc., a Delaware corporation (“HBB”).

We are a leading designer, marketer and distributor of a wide range of brand name small electric household and specialty housewares appliances, and commercial products for restaurants, fast food chains, bars and hotels, and a provider of connected devices and software for home healthcare management.

Our operations are managed and reported in two operating segments, each of which is a reportable segment for financial reporting purposes: (1) Home and Commercial Products and (2) Health.

The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the remainder of the year as our revenue typically increases during the second half of the year and peaks during the fourth quarter due to the fall holiday-selling season. Accordingly, quarter-to-quarter comparisons of our past operating results are meaningful only when comparing equivalent time periods, if at all.
Reclassification
Certain prior period amounts have been reclassified to conform to the current period classification. These reclassifications had no effect on the reported operating profit, net income, or stockholders’ equity.
Recently Issued Accounting Standards Not Yet Adopted
Recently Issued Accounting Standards Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires additional information to be disclosed about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
In September 2025, the FASB issued ASU 2025-06, “Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40):Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes previously written guidance around internal-use software costs by eliminating accounting consideration of software project development stages and provides for cost capitalization when management has authorized and committed funding to the project and that the project is considered ‘probable’ of completion and the software used to perform the function as intended, along with prescriptive disclosure requirements associated with internal-use software costs to be consistent with Subtopic 360-10, “Property, Plant and Equipment” regardless of how those costs are presented in the financial statements. The amendments are effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The amendment may be applied either retrospectively or prospectively or on a modified prospective basis prescribed by the ASU. The Company is currently evaluating the impact this ASU may have on our consolidated financial statements.

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow Scope Improvements.” The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for annual periods beginning after December 15, 2027, including interim periods within that annual period. The Company is currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
Accounts Payable - Supplier Finance Program
Accounts Payable - Supplier Finance Program
The Company has an agreement with a third-party administrator to provide an accounts payable tracking system which facilitates a participating supplier’s ability to monitor and voluntarily elect to sell payment obligations owed by the Company to the designated third-party financial institution. Participating suppliers can sell one or more of the Company’s payment obligations at their sole discretion. The Company has no economic interest in a supplier’s decision to sell one or more of its payment obligations. The Company’s rights and obligations with respect to such payment obligations, including amounts due and scheduled payment terms, are not impacted by suppliers’ decisions to sell amounts under these arrangements.
v3.26.1
Fair Value Disclosure (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table presents the Company’s assets and liabilities accounted for at fair value on a recurring basis:
DescriptionBalance Sheet LocationJUNE 30
2026
DECEMBER 31
2025
JUNE 30
2025
Assets:
Interest rate swap agreements
CurrentPrepaid expenses and other current assets$1,151 $831 $864 
Long-termOther non-current assets1,091 1,199 1,674 
$2,242 $2,030 $2,538 
Liabilities:
Foreign currency exchange contracts
CurrentOther current liabilities 126 1,223 
$ $126 $1,223 
v3.26.1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Capital Stock
The following table sets forth the Company’s authorized capital stock information:
JUNE 30
2026
DECEMBER 31
2025
JUNE 30
2025
Preferred stock, par value $0.01 per share
Preferred stock authorized5,000 5,000 5,000 
Preferred stock outstanding — — 
Class A Common stock, par value $0.01 per share
Class A Common authorized70,000 70,000 70,000 
Class A Common issued (1)(2)
12,083 11,870 11,821 
Treasury Stock (3)
2,219 2,052 1,941 
Class B Common stock, par value $0.01 per share, convertible into Class A Common stock on a one-for-one basis
Class B Common authorized30,000 30,000 30,000 
Class B Common issued (1)
3,584 3,587 3,596 

(1) Class B Common converted to Class A Common were 1 and 3 shares during the three and six months ended June 30, 2026, respectively, and 5 and 7 shares during the three and six months ended June 30, 2025, respectively.

(2) The Company issued Class A Common of 18 and 210 shares during the three and six months ended June 30, 2026, respectively, and 19 and 338 shares during the three and six months ended June 30, 2025, respectively.

(3) On February 20, 2026 and February 21, 2025, a total of 14 and 39 mandatory cashless-exercise-award shares of Class A Common, respectively, were surrendered to the Company by the participants of our Executive Long-Term Equity Incentive Compensation Plan (the “Incentive Plan”) in order to satisfy the participants’ tax withholding obligations with respect to shares of Class A Common awarded under the Incentive Plan.
Schedule of Accumulated Other Comprehensive Loss The following table summarizes changes in accumulated other comprehensive loss by component and related tax effects for periods shown:
Foreign CurrencyDeferred Gain (Loss) on Cash Flow Hedging Pension Plan AdjustmentTotal
Balance, January 1, 2026$(8,365)$1,096 $489 $(6,780)
Other comprehensive income (loss)(290)383  93 
Reclassification adjustment to net income (loss) 80 (6)74 
Tax effects (133) (133)
Balance, March 31, 2026(8,655)1,426 483 (6,746)
Other comprehensive income (loss)409 364  773 
Reclassification adjustment to net income (loss) (254)(2)(256)
Tax effects (28) (28)
Balance, June 30, 2026$(8,246)$1,508 $481 $(6,257)
Balance, January 1, 2025$(12,279)$3,572 $130 $(8,577)
Other comprehensive income (loss)327 (861)— (534)
Reclassification adjustment to net income (loss)— (654)64 (590)
Tax effects— 415 (16)399 
Balance, March 31, 2025(11,952)2,472 178 (9,302)
Other comprehensive income (loss)2,660 (1,567)— 1,093 
Reclassification adjustment to net income (loss)— (637)(630)
Tax effects— 617 — 617 
Balance, June 30, 2025$(9,292)$885 $185 $(8,222)
v3.26.1
Revenue (Tables)
6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table sets forth Company’s revenue on a disaggregated basis for the three and six months ended June 30:
THREE MONTHS ENDED
JUNE 30
SIX MONTHS ENDED
JUNE 30
2026202520262025
Type of good or service:
  Consumer products$122,201 $109,608 $228,321 $226,943 
  Commercial products16,296 14,643 28,221 26,935 
  Licensing2,152 2,208 4,136 4,768 
  Leasing1,983 1,311 3,917 2,496 
     Total revenues$142,632 $127,770 $264,595 $261,142 
v3.26.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The table below presents the revenues and significant expenses of the two reportable segments along with a reconciliation of segment profit (loss) to consolidated income (loss) before income taxes. Total assets by segment are not reported as the CODM does not regularly review asset information by segment.

THREE MONTHS ENDED JUNE 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$140,172 $2,460 $142,632 $126,072 $1,698 $127,770 
Less:
Cost of sales64,579 557 65,136 92,149 490 92,639 
Selling, general and administrative expenses32,485 1,805 34,290 27,111 2,072 29,183 
Segment profit (loss)$43,108 $98 $43,206 $6,812 $(864)$5,948 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,264)121 
Other (income) expense, net(160)(182)
Income (loss) before income taxes$44,630 $6,009 

SIX MONTHS ENDED JUNE 30
20262025
Home and Commercial ProductsHealthTotalHome and Commercial ProductsHealthTotal
Revenue$259,783 $4,812 $264,595 $257,900 $3,242 $261,142 
Less:
Cost of sales149,772 1,135 150,907 192,375 865 193,240 
Selling, general and administrative expenses62,028 3,486 65,514 55,528 4,113 59,641 
Segment profit (loss)$47,983 $191 $48,174 $9,997 $(1,736)$8,261 
Reconciliation of segment profit or (loss)
Interest (income) expense, net(1,342)49 
Other (income) expense, net(66)(331)
Income (loss) before income taxes$49,582 $8,543 
v3.26.1
Basis of Presentation and Recently Issued Accounting Standards (Details)
$ in Millions
6 Months Ended
Jun. 30, 2026
USD ($)
segment
Dec. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Basis of Presentation and Policies [Line Items]      
Number of operating segments | segment 2    
Number of reportable segments | segment 2    
Outstanding payment obligations, current $ 26.5 $ 29.9 $ 35.8
Limit on payment obligations 65.0    
Settlement of outstanding payment obligations 20.1 $ 21.8 $ 32.0
Letter of Credit | HBB Facility      
Basis of Presentation and Policies [Line Items]      
Line of credit facility, maximum borrowing capacity $ 125.0    
v3.26.1
Transfer of Financial Assets (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Transfers and Servicing [Abstract]          
Accounts receivable derecognized $ 0.0 $ 34.2 $ 4.3 $ 66.6 $ 145.0
Loss on sold receivables $ 0.0 $ 0.0 $ 0.0 $ 0.0  
v3.26.1
Fair Value Disclosure (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Assets:      
Assets at fair value $ 2,242 $ 2,030 $ 2,538
Liabilities:      
Foreign currency exchange contracts 0 126 1,223
Liabilities at fair value 0 126 1,223
Letter of Credit | HBB Facility      
Liabilities:      
Line of credit facility, maximum borrowing capacity 125,000    
Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent      
Assets:      
Interest rate swap agreements 1,091 1,199 1,674
Balance Sheet Location [Axis]: us-gaap:PrepaidExpenseAndOtherAssetsCurrent      
Assets:      
Interest rate swap agreements $ 1,151 $ 831 $ 864
v3.26.1
Stockholders’ Equity - Schedule of Capital Stock (Details)
shares in Thousands
3 Months Ended 6 Months Ended
Feb. 20, 2026
shares
Feb. 21, 2025
shares
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2025
$ / shares
shares
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2025
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Class of Stock [Line Items]              
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Preferred stock authorized (in shares)     5,000 5,000 5,000 5,000 5,000
Preferred stock outstanding (in shares)     0 0 0 0 0
Class A Common stock              
Class of Stock [Line Items]              
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock authorized (in shares)     70,000 70,000 70,000 70,000 70,000
Common stock issued (in shares)     12,083 11,821 12,083 11,821 11,870
Treasury stock (in shares)     2,219 1,941 2,219 1,941 2,052
Class A common shares issued (in shares)     18 19 210 338  
Number of shares surrendered to satisfy tax withholding obligation (in shares) 14 39          
Class B Common stock              
Class of Stock [Line Items]              
Common stock, par value (in dollars per share) | $ / shares     $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock, convertible conversion ratio     1 1 1 1 1
Common stock authorized (in shares)     30,000 30,000 30,000 30,000 30,000
Common stock issued (in shares)     3,584 3,596 3,584 3,596 3,587
Class B common converted to Class A common (in shares)     1 5 3 7  
v3.26.1
Stockholders’ Equity - Stock Repurchase Program (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Nov. 30, 2025
Class of Stock [Line Items]                
Shares repurchased (in shares) 97,869   215,297   166,857 395,853    
Shares repurchase price $ 1,957,000 $ 1,206,000 $ 3,974,000 $ 3,373,000 $ 3,200,000 $ 7,400,000    
2023 Stock Repurchase Program | Shares Outstanding Class A                
Class of Stock [Line Items]                
Approved repurchase amount               $ 25,000,000
2026 and 2027 Stock Repurchase Plan                
Class of Stock [Line Items]                
Shares repurchased (in shares) 97,869   215,297   153,282 356,732 467,804  
Shares repurchase price $ 2,000,000.0   $ 4,000,000.0   $ 2,900,000 $ 6,700,000 $ 8,300,000  
Remaining authorized repurchase amount $ 22,100,000       $ 22,100,000      
Incentive Plan                
Class of Stock [Line Items]                
Shares repurchased (in shares) 0   0   13,575 39,121    
Shares repurchase price         $ 300,000 $ 700,000    
v3.26.1
Stockholders’ Equity - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance $ 184,769 $ 182,845 $ 163,181 $ 165,903
Other comprehensive income (loss) 773 93 1,093 (534)
Reclassification adjustment to net income (loss) (256) 74 (630) (590)
Tax effects (28) (133) 617 399
Ending balance 216,734 184,769 163,975 163,181
Accumulated Other Comprehensive Income (Loss)        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (6,746) (6,780) (9,302) (8,577)
Ending balance (6,257) (6,746) (8,222) (9,302)
Foreign Currency        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (8,655) (8,365) (11,952) (12,279)
Other comprehensive income (loss) 409 (290) 2,660 327
Reclassification adjustment to net income (loss) 0 0 0 0
Tax effects 0 0 0 0
Ending balance (8,246) (8,655) (9,292) (11,952)
Deferred Gain (Loss) on Cash Flow Hedging        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 1,426 1,096 2,472 3,572
Other comprehensive income (loss) 364 383 (1,567) (861)
Reclassification adjustment to net income (loss) (254) 80 (637) (654)
Tax effects (28) (133) 617 415
Ending balance 1,508 1,426 885 2,472
Pension Plan Adjustment        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 483 489 178 130
Other comprehensive income (loss) 0 0 0 0
Reclassification adjustment to net income (loss) (2) (6) 7 64
Tax effects 0 0 0 (16)
Ending balance $ 481 $ 483 $ 185 $ 178
v3.26.1
Revenue - Narrative (Details)
6 Months Ended
Jun. 30, 2026
Commercial products | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | United States  
Disaggregation of Revenue [Line Items]  
Concentration risk, percentage (as percent) 66.66%
Maximum | Other products  
Disaggregation of Revenue [Line Items]  
Warranty term (in years) 3 years
Maximum | Consumer products  
Disaggregation of Revenue [Line Items]  
Revenue contract duration (in years) 1 year
Maximum | Commercial products  
Disaggregation of Revenue [Line Items]  
Revenue contract duration (in years) 1 year
Minimum | Other products  
Disaggregation of Revenue [Line Items]  
Warranty term (in years) 1 year
v3.26.1
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Leasing $ 1,983 $ 1,311 $ 3,917 $ 2,496
Total revenues 142,632 127,770 264,595 261,142
Consumer products        
Disaggregation of Revenue [Line Items]        
Revenue 122,201 109,608 228,321 226,943
Commercial products        
Disaggregation of Revenue [Line Items]        
Revenue 16,296 14,643 28,221 26,935
Licensing        
Disaggregation of Revenue [Line Items]        
Revenue $ 2,152 $ 2,208 $ 4,136 $ 4,768
v3.26.1
Contingencies (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Gain Contingencies [Line Items]        
Interest income $ 1,264 $ (121) $ 1,342 $ (49)
IEEPA Tariff Refund        
Gain Contingencies [Line Items]        
Tariff refunds recognized as a reduction of cost of sales 36,500   36,500  
Interest income $ 1,200   $ 1,200  
v3.26.1
Income Taxes (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Tax Disclosure [Abstract]        
Effective tax rate 24.50% 25.90% 24.90% 26.70%
v3.26.1
Segment Information - Narrative (Details)
6 Months Ended
Jun. 30, 2026
segment
Segment Reporting [Line Items]  
Number of operating segments 2
Number of reportable segments 2
Commercial products | United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk  
Segment Reporting [Line Items]  
Concentration risk, percentage (as percent) 66.66%
v3.26.1
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 142,632 $ 127,770 $ 264,595 $ 261,142
Less:        
Cost of sales 65,136 92,639 150,907 193,240
Selling, general and administrative expenses 34,290 29,183 65,514 59,641
Operating profit (loss) 43,206 5,948 48,174 8,261
Reconciliation of segment profit or (loss)        
Interest (income) expense, net (1,264) 121 (1,342) 49
Other (income) expense, net (160) (182) (66) (331)
Income (loss) before income taxes 44,630 6,009 49,582 8,543
Operating segments        
Segment Reporting [Line Items]        
Revenue 142,632 127,770 264,595 261,142
Less:        
Cost of sales 65,136 92,639 150,907 193,240
Selling, general and administrative expenses 34,290 29,183 65,514 59,641
Operating profit (loss) 43,206 5,948 48,174 8,261
Operating segments | Home and Commercial Products        
Segment Reporting [Line Items]        
Revenue 140,172 126,072 259,783 257,900
Less:        
Cost of sales 64,579 92,149 149,772 192,375
Selling, general and administrative expenses 32,485 27,111 62,028 55,528
Operating profit (loss) 43,108 6,812 47,983 9,997
Operating segments | Health        
Segment Reporting [Line Items]        
Revenue 2,460 1,698 4,812 3,242
Less:        
Cost of sales 557 490 1,135 865
Selling, general and administrative expenses 1,805 2,072 3,486 4,113
Operating profit (loss) 98 (864) 191 (1,736)
Reconciling Items        
Reconciliation of segment profit or (loss)        
Interest (income) expense, net (1,264) 121 (1,342) 49
Other (income) expense, net $ (160) $ (182) $ (66) $ (331)